SCHEMBL846485

SCHEMBL846485

CCCC(=O)N1CCc2cc(OC(=O)Nc3cnc4ccccc4c3)ccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.43
RAB9A P51151 3/20 0.43
TSHR P16473 2/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
ADRB2 P07550 2/20 0.43
ADRB1 P08588 2/20 0.43
ADRB3 P13945 2/20 0.43
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
NPC1 O15118 3/20 0.42
KDM4E B2RXH2 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TP53 P04637 1/20 0.42
TRPV1 Q8NER1 3/20 0.42
GAA P10253 2/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
GFER P55789 1/20 0.42
SLC2A1 P11166 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL846869 0.88 NOTUM (0.50) HSD17B10RAB9ATSHRCYP11B1CYP11B2
SCHEMBL846566 0.86 HSD17B10 (0.44) HSD17B10RAB9ATSHRLMNAPOLB
SCHEMBL847037 0.85 TRPV1 (0.56) RAB9ANPC1KDM4ETRPV1
SCHEMBL846528 0.85 KDR (0.48) HSD17B10RAB9ALMNAPOLBNPC1
SCHEMBL846407 0.84 NPC1 (0.47) HSD17B10RAB9ATSHRLMNAPOLB
SCHEMBL846954 0.83 TRPV1 (0.45) HSD17B10RAB9ATSHRLMNAPOLB
SCHEMBL846565 0.82 SMN1; SMN2 (0.47) HSD17B10RAB9ATSHRLMNAPOLB
SCHEMBL847501 0.81 KDM4E (0.48) HSD17B10RAB9ATSHRLMNAPOLB
SCHEMBL846419 0.80 ACHE (0.47) HSD17B10RAB9ANPC1KDM4ESMN1; SMN2
SCHEMBL846445 0.78 KDM4E (0.48) HSD17B10RAB9ALMNANPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603883-B1 QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR JANSSEN PHARMACEUTICA NV (BE) 2012-03-28 EP claimed